Testing MOUD Scale-Up in Correctional Institutions

This study is testing ways to increase the use of Medications for Opioid Use Disorder (MOUD) in prisons. MOUD are treatments that help people with opioid addiction. Researchers will try out two strategies: a policy academy and a learning collaborative. The goal is to see if these methods can help more incarcerated individuals get MOUD, which is important because it can reduce overdose deaths after release. The study aims to measure how much these strategies help prisons offer MOUD over two years. This study is for correctional institutions that want to offer or increase MOUD, have funds for the medication, and have support from their leadership. The current recruitment status is unclear.

Study design
This interventional study will involve 120 correctional institutions across 12 U.S. states. It will evaluate two different strategies to scale up MOUD programs.
What's involved
The learning collaborative involves learning sessions at the beginning and monthly coaching sessions for 12 months. This is to help staff implement the study protocol and understand MOUD.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome, reach of systems-change for scaling MOUD, will be measured at 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07224516

Testing MOUD Scale-Up

Recruiting
NAAges 18+InterventionalHealth services
University of Wisconsin, Madison
~120 participants
Updated 2026-02-13 on ClinicalTrials.gov
What's tested:SAMHSALearning Collaborative

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Reach of systems-change for scaling medications for MOUD
Measured over 2 years
Incarcerated Individuals
Correctional Institutions
1 sites across 1 states
Wisconsin1
  • Todd Molfenter, PhD · PRINCIPAL_INVESTIGATOR · University of Wisconsin, Madison
  • Rosemarie Martin, PhD · PRINCIPAL_INVESTIGATOR · University of Wisconsin, Madison

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Have an interest in embedding or increasing the use of MOUD within their site
Have the funds to pay for medication for the duration of the study (24 months)
Agree to implement or continue the use of at least one medication for opioid use disorder
Have leadership support at all levels including from Secretary of DOC, medical director, wardens, etc.
Sign a memorandum of Understanding (MOU) or Information Sheet
Agree to provide data described in the Information Sheet

Exclusion

Failure to meet eligibility criteria
  • Reach of systems-change for scaling medications for MOUD2 years

    Using the RE-AIM framework, reach is measured by number of MOUD (buprenorphine, methadone, injectable naltrexone) standardized medication units purchased by prisons in a state